医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

GVK BIO Establishes the Largest Isotope Labeling Facility in India

2012年11月19日 PM03:25
このエントリーをはてなブックマークに追加


 

HYDERABAD, India

GVK Biosciences (GVK BIO), Asia’s leading Drug Discovery Research & Development organization, has received approvals from the Atomic Energy Regulatory Board (AERB), Government of India, to carry out 3H and 14C synthesis activities. This GLP compliant facility has state-of-the-art equipment to cater to the requirements of companies engaged in the fields of Drug Discovery and Development, Agro and Veterinary Chemicals, Cosmetics, Perfumery and Specialty Studies.

Speaking of this development, Manni Kantipudi, CEO, GVK BIO, said, “Several of our customers requested us to extend our chemistry services to include isotope labeling services. We listened to our customers and setup this state-of-the art facility which is the largest such facility in India. The facility has received all statutory approvals from the Atomic Energy Review Board of India.

About GVK Biosciences

GVK Biosciences (GVK BIO) is Asia’s leading contract research organization. GVK BIO provides a broad spectrum of services, stand-alone and integrated, across the R&D value chain. Our discovery services consist of Chemistry, Biology and Informatics; the development services include Clinical Research, Clinical Pharmacology and Process R&D. GVK BIO’s diverse portfolio of nearly 200 customers includes some of the world’s largest pharmaceutical, biotechnology, agro, life-sciences companies and leading academic & research institutions. Please visit us at www.gvkbio.com to know more.

CONTACT

GVK Biosciences Private Limited
Sushant Datta
Dy General
Manager – Corporate Marketing
T 0091 40 66929999
E sushant.datta@gvkbio.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Cerveau Technologies, Inc. Signs Research Agreement with Kobe City Hospital Organisation, Japan
  • Exactech Earns Research Award at International Computer-Assisted Surgery Conference for ExactechGPS® Knee Application
  • 火山噴火で家屋の破壊と住民の避難が続く中、ハワイ・コミュニティ財団が支援基金を創設
  • Octapharma宣布Nuwiq®产品新增剂量规格在欧洲获准,提高了血友病A患者的给药灵活性
  • PHCホールディングス株式会社:薬剤師の業務効率化を目指した保険薬局用電子薬歴システム「PharnesV-MX」を販売開始